These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9177370)

  • 1. Predictors of early remission of hyperthyroidism in children.
    Glaser NS; Styne DM
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1719-26. PubMed ID: 9177370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and gender predict the outcome of treatment for Graves' hyperthyroidism.
    Allahabadia A; Daykin J; Holder RL; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1038-42. PubMed ID: 10720036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hyperthyroidism: aetiology, clinical features and treatment outcome.
    Iglesias P; Dévora O; García J; Tajada P; García-Arévalo C; Díez JJ
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):551-7. PubMed ID: 19681915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy.
    Shulman DI; Muhar I; Jorgensen EV; Diamond FB; Bercu BB; Root AW
    Thyroid; 1997 Oct; 7(5):755-60. PubMed ID: 9349579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
    Glaser NS; Styne DM;
    Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile hyperthyroidism: an experience.
    Bhadada S; Bhansali A; Velayutham P; Masoodi SR
    Indian Pediatr; 2006 Apr; 43(4):301-7. PubMed ID: 16651668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment.
    Kaguelidou F; Alberti C; Castanet M; Guitteny MA; Czernichow P; Léger J;
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3817-26. PubMed ID: 18628515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study.
    Léger J; Gelwane G; Kaguelidou F; Benmerad M; Alberti C;
    J Clin Endocrinol Metab; 2012 Jan; 97(1):110-9. PubMed ID: 22031519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
    Takamatsu J; Kuma K; Mozai T
    J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years.
    Lippe BM; Landaw EM; Kaplan SA
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1241-5. PubMed ID: 3571426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of pediatric Graves' disease.
    Jevalikar G; Solis J; Zacharin M
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1131-6. PubMed ID: 24945422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy.
    Kawamura S; Kishino B; Tajima K; Mashita K; Tarui S
    J Clin Endocrinol Metab; 1983 Mar; 56(3):507-12. PubMed ID: 6185525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid diseases in sub-Saharan Africa].
    Sidibé el H
    Sante; 2007; 17(1):33-9. PubMed ID: 17897900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.